« Previous
Next »
Parkinsonism & Related Disorders
Volume 15, Issue 1
, Pages 30-35
, January 2009
Effects of zonisamide on c-Fos expression under conditions of tacrine-induced tremulous jaw movements in rats: A potential mechanism underlying its anti-parkinsonian tremor effect
References
- . Zonisamide has beneficial effects on Parkinson's disease patients. Neurosci Res. 2001;41:397–399
- . Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease. Curr Pharm Des. 2004;10:687–693
- . Zonisamide for the treatment of Parkinson's disease. Expert Rev Neurother. 2007;7:1077–1083
- . Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study. Neurology. 2007;68:45–50
- . Effect of zonisamide on resting tremor resistant to antiparkinsonian medication. No To Shinkei. 2003;55:685–689
- . Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. Parkinsonism Relat Disord. 2005;11:101–103
- . Zonisamide in patients with essential tremor and Parkinson's disease. Mov Disord. 2007 Oct 31;22(14):2137–2138
- . Effects of zonisamide on experimental tremors in rats. Parkinsonism Relat Disord. 2008;14:33–36
- . Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects. Pharmacol Biochem Behav. 1997;56:273–279
- . Tremulous jaw movements in rats: a model of parkinsonian tremor. Prog Neurobiol. 1998;56:591–611
- . The role of ventrolateral striatal acetylcholine in the production of tacrine-induced jaw movements. Pharmacol Biochem Behav. 1999;62:439–447
- Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents: implications for cholinergic involvement in parkinsonism. Life Sci. 2001;68:2579–2584
- . Rodent models of tremor. Cerebellum. 2007;6:66–72
- . Differential expression of c-fos following administration of two tremorgenic agents: harmaline and oxotremorine. NeuroReport. 2000;11:2385–2390
- . Mapping patterns of c-fos expression in the central nervous system after seizure. Science. 1987;237:192–197
- . Neural activity mapping with inducible transcription factors. NeuroReport. 1997;8:iii–vii
- . Metabolic mapping with cellular resolution: c-fos vs. 2-deoxyglucose. Crit Rev Neurobiol. 1993;7:205–228
- . Muscarinic receptor-mediated induction of Fos protein in rat brain. Neurosci Lett. 1993;150:122–126
- Expression of c-fos protein in the experimental epilepsy induced by pilocarpine. Synapse. 1993;14:1–9
- . Behavioral and electromyographic characterization of the local frequency of tacrine-induced tremulous jaw movements. Physiol Behav. 1998;64:153–158
- . Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev. 1995;47:133–178
- . Axonal projections from the parasubthalamic nucleus. J Comp Neurol. 2004;469:581–607
- . Alternative pathways for catecholamine action in oral motor control. Neurosci Lett. 2005;386:34–39
- . Evidence for a role of the shell of the nucleus accumbens in oral behavior of freely moving rats. J Neurosci. 1994;14:1555–1562
PII: S1353-8020(08)00090-4
doi: 10.1016/j.parkreldis.2008.02.008
« Previous
Next »
Parkinsonism & Related Disorders
Volume 15, Issue 1
, Pages 30-35
, January 2009
